News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Galenica Pharmaceuticals Shares Soar After U.S. FDA Backs Ferinject
February 4, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Feb 4 (Reuters) - Shares in Swiss healthcare provider Galenica jumped 15 percent on Monday after a U.S. Food and Drug Administration advisory panel surprised investors by backing its Ferinject anaemia drug.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 2
Phase 3
Europe
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Podcast
As FDA Moves Away From Animal Testing, AI and Organoids Can Shine
February 17, 2026
·
1 min read
·
Jef Akst
Vaccines
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait
February 16, 2026
·
3 min read
·
Annalee Armstrong
Rare diseases
‘Highly Impressive’ Data Propels BridgeBio’s Achondroplasia Drug Forward
February 12, 2026
·
2 min read
·
Tristan Manalac
Insights
Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment
February 12, 2026
·
1 min read
·
Jennifer Smith-Parker
